We are live on
!
Find out more
PC
Paulson & Co Portfolio holdings
AUM
$3.11B
1-Year Est. Return
94.93%
This Fund
S&P 500
This Quarter
Est. Return
+52.53%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$3.13B
AUM Growth
+$509M
(+19%)
Cap. Flow
-$424M
Cap. Flow
% of AUM
-13.55%
Top 10 Holdings %
Top 10 Hldgs %
79.25%
Holding
37
New
4
Increased
2
Reduced
10
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$88.1M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$36.7M |
| 3 |
Qiagen
QGEN
|
+$23.7M |
| 4 |
Equinox Gold
EQX
|
+$22.4M |
| 5 |
TCO
Taubman Centers Inc.
TCO
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AngloGold Ashanti
AU
|
+$108M |
| 2 |
AGN
Allergan plc
AGN
|
+$107M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$85.4M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$54.7M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$45.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.82% |
| 2 | Materials | 23.67% |
| 3 | Financials | 9.1% |
| 4 | Communication Services | 5.68% |
| 5 | Industrials | 0.37% |
Similar funds
TCG
CCI
KF
AWM
DIG
EAM
LFG
DCM
Paulson & Co's Q2 2020 Portfolio in Review
As of Q2 2020, Paulson & Co held 37 positions worth $3.13B, up 19% from $2.62B the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Paulson & Co withdrew a net $424M in Q2 2020, closing 7 positions and reducing 10 holdings. Its most notable exit was Allergan plc, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 44% a quarter earlier, followed by Materials and Financials.
Against the trend, Paulson & Co opened a new position in TD Ameritrade Holding Corp worth $35.5M.
- Paulson & Co's largest Q2 2020 buy was TD Ameritrade Holding Corp: 975,000 shares worth $35.5M.
- Paulson & Co added most to Bausch Health in Q2 2020, an estimated $88.1M increase.
- Paulson & Co's biggest Q2 2020 reduction was AngloGold Ashanti, cutting an estimated $108M.
- Paulson & Co fully exited Allergan plc in Q2 2020, selling an estimated $107M.
- Paulson & Co's ten largest holdings make up 79% of its $3.13B portfolio in Q2 2020.
- Paulson & Co opened 4 new positions and closed 7 in Q2 2020.
- Paulson & Co's portfolio value rose 19% quarter-over-quarter to $3.13B.
Based on Paulson & Co's 13F filing for Q2 2020, filed 14 Aug 2020.